Related Experiment Video

Updated: Jul 16, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Selection of statin considering the HDL cholesterol level]

Akos Kalina1

  • 1MAV Kórház és Központi Rendelointézet, Kardiológia, Budapest. kalinaak@t-online.hu

Orvosi Hetilap
|March 27, 2007
PubMed

Insights

Low high-density lipoprotein (HDL) cholesterol is a risk factor for cardiovascular disease. Simvastatin effectively increases HDL cholesterol levels more than atorvastatin, aiding therapeutic goals in high-risk patients.

Area of Science:

  • Cardiology
  • Pharmacology
  • Metabolic Disorders

Background:

  • Low high-density lipoprotein (HDL) cholesterol is an independent risk factor for cardiovascular diseases (CVD).
  • Therapeutic strategies aim to increase HDL cholesterol levels, particularly in high-risk populations such as those with CVD, diabetes, or metabolic syndrome.
  • Target HDL cholesterol levels are >1.0 mmol/l for males and >1.3 mmol/l for females in high-risk individuals.

Purpose of the Study:

  • To compare the efficacy of simvastatin versus atorvastatin in increasing HDL cholesterol levels.
  • To highlight the importance of optimizing HDL cholesterol alongside LDL cholesterol targets in patient therapy.

Main Methods:

  • Review of clinical trials and pharmacological data on statin effects on HDL cholesterol metabolism.
  • Analysis of the role of Peroxisome Proliferator-Activated Receptor alpha (PPARα) in HDL cholesterol regulation.

Main Results:

  • Simvastatin demonstrated a superior effect in increasing HDL cholesterol levels compared to atorvastatin.
  • Both fibrates and statins influence HDL cholesterol metabolism via PPARα receptor activity.
  • Clinical trials support the positive effect of simvastatin on HDL cholesterol.

Conclusions:

  • Simvastatin is a more effective option than atorvastatin for improving HDL cholesterol levels.
  • Optimizing HDL cholesterol is a crucial component of cardiovascular risk management, complementing LDL cholesterol goal achievement.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...